Description: Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Home Page: www.futuramedical.com
Surrey Technology Centre
Guildford,
GU2 7YG
United Kingdom
Phone:
44 14 8368 5670
Officers
| Name | Title |
|---|---|
| Mr. James Henry Barder | CEO & Executive Director |
| Ms. Angela Hildreth | COO, Finance Director, Company Secretary & Executive Director |
| Mr. Kenneth William James | Head of R&D & Executive Director |
| Dr. William Duncan Potter | Chief Scientific Officer & Adviser to the Board |
| Graham Smith | Head of Alliance Partnerships & Supply |
| Kevin Langridge | Head of Quality |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 10.8932 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 12.1973 |
| Price-to-Sales TTM: | 14.4071 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 12 |